​

Our Clinical Trial Investigative Sites

 

The DELTA HEALTH GROUP operates a global network of dedicated and strategically located clinical trial investigative sites in the United States, Canada and the Asian continent

 

• ​With advanced infrastructure and world-class medical facilities, these high-performance international investigative sites include partner Phase 1 Clinics and dedicated Phase 2 and pivotal Phase 3 medical centers and hospitals that are focused on conducting US FDA drug development clinical trials

​​

• Based on the maxim.....Experience.....Integrity.....Quality, we believe in running clinical trials where the patient populations are located. This includes running new drug development trials at our premier sites in Asia by reaching out to diverse, treatment naive patient populations

​

• DELTA HEALTH has long-term exclusivity agreements with prominent teaching hospitals and clinics in Asia to operate and manage state-of-the-art, multi-specialty, clinical investigative sites having extensive experience in conducting drug development clinical trials according to ICH Good Clinical Practice Guidelines. Covering a multi-million, diverse ethnic catchment area population, these clinical facilities have preferred access to a fast growing and highly compliant, local clinical trial subject populace ​

​​

​

• The clinical trial facilities in Asia are directly mentored and managed by the DELTA HEALTH team members stationed locally on the ground. These Delta Specialists have in-depth knowledge and hands-on experience with the direct management of successful US FDA clinical trials and investigative sites

​​

 

• With 60% - 70% drug development clinical trials resulting in failure due to patient recruitment inability or delays and another significant number falling short of meeting study objectives, the DELTA HEALTH operated investigative sites in Asia work diligently with key stakeholders to take challenges head-on and make smart decisions to overcome common obstacles seamlessly  

​​

​

• Speedy start-up of clinical trials, enrollment of compliant patients and collection of clean, audit ready data is ensured by the US FDA seasoned and vetted DELTA HEALTH team

​​

​

• Supported by AI optimization tools and advanced Data Management systems, the operational excellence of our EMR and EDC savvy teams give us the capability to run clinical trials at multiple sites simultaneously   

​​

 

• Modern, internationally certified clinical laboratories and diagnostic facilities with in-house CT scans and MRIs provide dedicated support throughout the duration of ongoing clinical trials 

​​

​

• Bereft the red-tapism and overheads of industry giants, engaging the DELTA HEALTH clinical trial sites will dramatically cut study timelines to accelerate the successful execution of partner clinical development programs

​​

 

​Collaborate with the DELTA HEALTH GROUP to expand your existing site network and partner with us to conduct your studies at our premier international clinical trial investigative sites.